SCHEMBL21691641

SCHEMBL21691641

N#Cc1c(-c2cccc3c2sc2ccccc23)ccc(-c2cccc3c2sc2ccccc23)c1-c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.44
PARP14 Q460N5 1/20 0.41
ALDH1A1 P00352 3/20 0.36
HSD17B10 Q99714 2/20 0.36
ALOX15 P16050 1/20 0.36
PDE9A O76083 1/20 0.36
HTT P42858 2/20 0.36
MAPT P10636 1/20 0.36
TNKS O95271 1/20 0.35
TNKS2 Q9H2K2 1/20 0.35
PRKDC P78527 3/20 0.35
SQOR Q9Y6N5 2/20 0.34
GPR3 P46089 1/20 0.34
ADORA2A P29274 3/20 0.34
PIK3CD O00329 2/20 0.34
PIK3CB P42338 2/20 0.34
BRD4 O60885 1/20 0.34
PIK3CA P42336 1/20 0.34
MTOR P42345 1/20 0.34
PIK3CG P48736 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21692485 0.89 ALOX5 (0.47) ALOX5PARP14ALDH1A1HSD17B10ALOX15
SCHEMBL21693264 0.88 ADORA2A (0.43) ALOX5PARP14ALDH1A1HSD17B10ALOX15
SCHEMBL21692631 0.85 PARP14 (0.40) ALOX5PARP14HTTMAPTPRKDC
SCHEMBL21692486 0.84 ALOX5 (0.45) ALOX5PARP14ALDH1A1HSD17B10ALOX15
SCHEMBL10029289 0.84 ALOX5 (0.54) ALOX5PARP14TNKSTNKS2PRKDC
SCHEMBL21692643 0.84 ALDH1A1 (0.36) ALDH1A1HSD17B10ALOX15PDE9AHTT
SCHEMBL21691806 0.83 ALOX5 (0.44) ALOX5PARP14ALDH1A1HSD17B10MAPT
SCHEMBL21691752 0.83 ALOX5 (0.41) ALOX5PARP14ALDH1A1HSD17B10ALOX15
SCHEMBL21693070 0.82 ALOX5 (0.48) ALOX5PARP14ALDH1A1TNKSTNKS2
SCHEMBL21692367 0.82 ALOX5 (0.46) ALOX5PARP14ALDH1A1HSD17B10ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11053228-B2 Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-07-06 US disclosed
US-20200031812-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND SAMSUNG SDI CO., LTD. (KR) 2020-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11053228-B2 Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound CCNL2, ARL1, CRY1 ALOX5 2220/4885PARP14 1715/4885ALDH1A1 738/4885
US-20200031812-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND CCNL2, ARL1, CRY1 ALOX5 2220/4885PARP14 1715/4885ALDH1A1 738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.